Species of Acinetobacter other than Acinetobacter baumannii are involved in nosocomial infections. Acinetobacter lwoffii, Acinetobacter genomospecies 3 and Acinetobacter genomospecies 13TU are found in community- and nosocomial-acquired infections as well as in neonatal intensive care units. The non-baumannii Acinetobacter are normally highly susceptible to ciprofloxacin, ampicillin/sulbactam, gentamicin and tigecycline. Carbepenems show good activity although resistant isolates have been reported. Resistance to β-lactams other than carbapenems is associated with overexpression of chromosomal cephalosporinases and extended-spectrum β-lactamase acquisition, whereas resistance to carbapenems involves acquisition of carbapenemases. Quinolone resistance is related to gyrA and/or parC mutations but overexpresion of efflux proteins also plays an important role. With the development of novel and more accurate typing methodologies, an increase in infections caused by non-baumannii Acinetobacter might be observed in the future.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.2217/fmb.11.30 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
The presence of genes encoding carbapenem-hydrolyzing oxacillinase and lack of carbapenem resistance in non-baumannii Acinetobacter misidentified as Acinetobacter baumannii causing bloodstream infections in a tertiary hospital over a 3-year period.
Infect Genet Evol
November 2024
Department of Infectious Disease, Nanjing Drum Tower Hospital, Nanjing Drum Tower Hospital Clinical College of Nanjing Medical University, Nanjing, China. Electronic address:
Objective: This study aims to analyze the genomic and clinical characteristics of Non-baumannii Acinetobacter strains misidentified as A. baumannii, causing bloodstream infections (BSIs) in our hospital.
Materials And Methods: Whole genome sequencing was performed and average nucleotide identity (ANI) was analyzed.
Characterization of a colistin resistant, hypervirulent hospital isolate of Acinetobacter courvalinii from Canada.
Eur J Clin Microbiol Infect Dis
October 2024
Department of Microbiology, University of Manitoba Winnipeg, Winnipeg, MB, R3T 2N2, Canada.
Non-baumannii Acinetobacter spp. are becoming more prevalent in clinical settings including those that present resistance to last-resort antibiotics such as colistin. AB222-IK40 is an Acinetobacter courvalinii strain isolated from the Ottawa Hospital Research Institute located in Ottawa, Canada.
View Article and Find Full Text PDFAntimicrobial resistance genes harbored in invasive complex isolated from Korean children during the pre-COVID-19 pandemic periods, 2015-2020.
Front Cell Infect Microbiol
July 2024
Department of Pediatrics, College of Medicine, Seoul National University, Seoul, Republic of Korea.
Article Synopsis
- The study investigates antibiotic resistance in Acinetobacter baumannii (AB) and non-baumannii Acinetobacter complex (NB-ACB) in invasive infections among Korean children.
- A total of 67 isolates were collected, with a high percentage of AB (73.1%) demonstrating significant multi-drug resistance, especially within the clonal complex 92.
- The research emphasizes the necessity for continued monitoring and analysis of resistance genes to effectively manage drug-resistant infections, particularly those involving CC92 AB.
Coexistence of β-lactamase genes and biofilm forming potential among carbapenem-resistant Acinetobacter baumannii in Lahore, Pakistan.
J Infect Dev Ctries
June 2024
Institute of Microbiology and Molecular Genetics, University of the Punjab, Lahore, Pakistan.
Article Synopsis
- The study aimed to examine antimicrobial resistance and biofilm formation in Acinetobacter from healthcare settings in Pakistan, focusing on beta-lactamase genes.
- A total of 223 imipenem-resistant Acinetobacter isolates were investigated using various tests, including PCR and sequencing, to identify resistance genes and biofilm production.
- The findings revealed high prevalence of carbapenem-resistant Acinetobacter, particularly associated with wound infections, and common genes linked to resistance and virulence, indicating a significant public health concern.
The Distribution of Carbapenem-Resistant Acinetobacter Species and High Prevalence of CC92 OXA-23-Producing in Community Hospitals in South Korea.
Infect Drug Resist
April 2024
Department of Companion Animal Health and Science, Silla University, Busan, South Korea.
Background: Clinical isolates of species in South Korea are continuously exhibiting high rates of antimicrobial resistance to carbapenems, indicating that there are public health concerns among both healthcare-associated infections and community-associated infections. The aim of this study was to describe the prevalence and characteristics of carbapenem-resistant isolates originating from community hospitals.
Materials And Methods: A total of 817 non-duplicated species were isolated from December 2022 to July 2023 at long-term care facilities and general hospitals in 16 regions geographically distributed throughout South Korea.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!